The signaling pathway responsible for the activation of nuclear factor-kB (NF-kB) by oncogenic forms of Ras remains unclear. Both, the transactivation and DNA binding activities of NF-kB, were increased in 267B1 human prostate epithelial cells transformed by viral Kirsten-ras (267B1/Ki-ras cells) compared with those in the parental cells. This increased NF-kB activity was attributed to a heterodimeric complex of p50 and p65 subunits. Although the abundance of the inhibitor protein IkBb was higher in 267B1/Ki-ras cells than in 267B1 cells, an electrophoretic mobility-shift assay suggested that IkBa is responsible for the activation of NF-kB in the former cells. Consistent with this notion, the phosphorylation of IkBa appeared increased in 267B1/ Ki-ras cells, and the proteasome inhibitor I abolished the constitutive activation of NF-kB in these cells. The expression of dominant negative mutants of either NIK (NF-kB-inducing kinase) or IKKb (IkB kinase b) inhibited the activity of NF-kB in 267B1/Ki-ras cells. Furthermore, chemical inhibitors speci®c for Ras activation, sulindac sul®de and farnesytranferase inhibitor I, markedly reduced IkBa phosphorylation and NF-kB activation in the Ki-ras-transformed cells while transfection of these cells with NIK or IKKb counteracted the inhibitory eect on NF-kB activation. These results suggest that oncogenic Ki-Ras induces transactivation of NF-kB through the NIK-IKKb-IkBa pathway.
Introduction
The transcription factor NF-kB is activated by a variety of stimuli, including proin¯ammatory cytokines, growth factors, and oncogenic transformation. In resting cells, NF-kB exists in the cytosol as a homoor heterodimer of various subunits, which, in mammals, include NF-kB1 (also known as p50), NF-kB2 (p52), RelA (p65), RelB, and c-Rel (Siebenlist et al., 1994; Miyamoto and Verma, 1995) . All of these proteins contain a conserved Rel homology domain (RHD) that is responsible for dimerization, DNA binding, and interaction with IkB inhibitor proteins. Among the various NF-kB dimers, the complex consisting of p65 and p50 is the most abundant in most cell types.
IkB proteins contain either six or seven ankyrin repeats, which mediate binding to the RHD and mask the nuclear localization signal of NF-kB subunits. Seven mammalian members of the IkB family ± IkBa, IkBb, IkBg, IkBe, Bcl-3, and the precursors of NF-kB1 (p105) and of NF-kB2 (p100) ± have been identi®ed (Whiteside and Israel, 1997) . Cell stimulation induces the phosphorylation of IkB proteins and their subsequent degradation, thereby allowing the translocation of NF-kB to the nucleus, where it binds to, and activates the transcription of, target genes. Whereas IkBa responds rapidly to agonist stimulation, IkBb is degraded more slowly; this dierence in degradation rate is associated with a dierence in the serine residues of these proteins phosphorylated by upstream kinases: Ser 32 and Ser 36 in IkBa, and Ser 19 and Ser 23 in IkBb (DiDonato et al., 1996; Ghosh et al., 1998) .
The IkB kinase (IKK) complex, with a molecular size of *700 to 900 kDa (DiDonato et al., 1997; Mercurio et al., 1997; Zandi et al., 1997) , is a key mediator of NF-kB activation. IKKb contributes to the proin¯ammatory response (Li et al., 1999; Tanaka et al., 1999) , whereas IKKa and IKKg participate predominantly in cell dierentiation and in structural regulation of the signalosome complex, respectively (DiDonato et al., 1997; Mercurio et al., 1997; Makris et al., 2000; Schmidt-Supprian et al., 2000) . IKKe was also recently identi®ed in a complex of 350 kDa (Peters et al., 2000) . The IKK complex is responsible for the phosphorylation of IkB proteins on serine residues, which results in their ubiquitination and degradation by the multicatalytic proteinase complex (20S proteasome) (DiDonato et al., 1996; Ghosh et al., 1998) . Tumor necrosis factor-a (TNF-a) activates IKKa and IKKb, an eect that is mediated by NFkB-inducing kinase (NIK) (Ozes et al., 1999) . In addition, NF-kB-activating kinase (NAK) was recently shown to activate IKKb and to induce phosphorylation of IkBa on Ser 36 in response to phorbol 12-myristate 13-acetate or platelet-derived growth factor (Tojima et al., 2000) .
Several signaling pathways, including IKK-dependent nuclear translocation, appear to mediate the activation of NF-kB by Ras. Stable transformation of cells with oncogenic H-ras has thus been shown to increase the transactivation activity of NF-kB through either a Raf-dependent or Raf-independent pathway, without inducing the translocation of NFkB to the nucleus (Finco et al., 1997; Norris and Baldwin, 1999; Caunt et al., 2001) . However, Arsura et al. (2000) has reported that Ha-Ras increases transcription and DNA-binding activity of NF-kB through Raf-MEK-IKKb and PI3K-IKKa. Melanoma growth stimulatory activity/growth-regulated protein (MGSA/GRO) also activates NF-kB through a signaling pathway that includes Ras, MEKK1, and the mitogen-activated protein kinase (MAPK) p38 (Wang and Richmond, 2001 ). In addition, Rasmediated activation of phosphoinositide 3-kinase (PI3K) and Akt has also been associated with IKK activation and Bad phosphorylation, resulting in cell proliferation and inhibition of apoptosis (Tang et al., 2000) . However, given that MMAC (PTEN), a natural antagonist of PI3K activity, was shown to inhibit the activation of NF-kB by interleukin-1 without aecting the IkB degradation pathway (Koul et al., 2001) , it remains unclear how PI3K and Akt mediate the activation of NF-kB.
Of the three genes in the ras family (Ki-ras, N-ras, and Ha-ras), Ki-ras appears to be mutated most frequently in human tumors, including pancreatic (70 to 90%), colon (50%), and lung (25 to 50%) adenocarcinomas (Bos et al., 1987; Mills et al., 1995; Johnson et al., 2001) . Disruption of Ki-ras was also shown to result in down-regulation of both urokinase receptor expression and plasminogen-dependent proteolysis in the invasive colon cancer cell line HCT116 (Allgayer et al., 1999) . Moreover, Ki-ras, but not Haras or N-ras, appears to be essential for normal mouse development (Umano et al., 1995; Johnson et al., 1997) . RelA is constitutively activated in pancreatic adenocarcinoma and pancreatic tumor cells expressing a mutant Ki-ras ; this activation was suggested to be dependent on Ras, Raf, and MEKK1. However, other studies have shown that Ki-Ras inhibits the activity of MAPK through MEK-dependent induction of MAPK phosphatase 2 (MKP2) (YipSchneider et al., 1999 (YipSchneider et al., , 2001 .
Ki-ras is also mutated in many human prostate carcinomas induced by N-methyl-N-nitrosourea (Sukumar et al., 1991) . We have now investigated the mechanism of Ki-Ras-induced activation of NF-kB in 267B1 human fetal prostate epithelial cells. These cells were immortalized by introduction of the SV40 large T antigen, and their further infection with Kirsten murine sarcoma virus, yielding 267B1/Ki-ras cells, was associated with the generation of a malignant phenotype (Parda et al., 1993) . We have now shown that the overexpression of Ki-Ras in the 267B1/Ki-ras cells increases both the transactivation activity of NF-kB through the NIK, IKKb and IkBa cascade.
Results

Ki-Ras-induced activation of NF-kB
Using human fetal prostate epithelial (267B1) cells and their Ki-ras-transformed (267B1/Ki-ras) derivatives, we examined the eects of Ki-Ras on NF-kB activation. The latter cells were characterized as transformed on the basis of morphological changes, and they form tumors in vivo (Parda et al., 1993) . The 267B1/Ki-ras cells also overexpress the Ki-ras product p21 ( Figure  1a ). The eect of Ki-Ras on the transactivation activity of NF-kB was examined with a luciferase reporter gene assay. Both 267B1 and 267B1/Ki-ras cells were transfected with pNF-kB-luc, which contains the luciferase gene under the control of the NF-kBregulated promoter, and 24 h later, the relative luciferase activities of cell lysates were measured ( Figure 1b) . The transactivation activity of NF-kB in 267B1/Ki-ras cells was increased about sixfold compared with that in 267B1 cells, suggesting that Ki-Ras activates NF-kB. To examine the eect of Ki-Ras on the subcellular localization and DNA binding activity of NF-kB, we performed electrophoretic mobility-shift assay (EMSA) analysis. The DNA binding activity of NF-kB in nuclear extracts of 267B1/Ki-ras cells was markedly increased relative to that in nuclear extracts of 267B1 cells (Figure 1c ). These results suggested that Ki-Ras induces both the nuclear translocation and activation of NF-kB.
To identify the signaling pathway by which Ki-Ras induces the activation of NF-kB, we exposed 267B1/ Ki-ras cells that had been transfected with pNF-kB-luc to various chemical inhibitors for 24 h, including PD98059 at 4 mM (for MEK), SB202190 at 5 mM (for p38 MAPK), and proteasome inhibitor I at 1 and 5 mM. Furthermore, 50 mM concentrations of these inhibitors had no eect on the Ki-Ras-induced activation of NF-kB (Figure 1b) . No cytotoxicity was observed following treatment of these cells with these concentrations of inhibitors. The speci®city of either PD98059 or SB202190 was con®rmed by determining the phosphorylation status of p42 and p44 or p38 in the two cell lines, respectively ( Figure 1d ). Immunoblot analysis revealed that 267B1/Ki-ras cells exhibit phosphorylated forms of p42 and p44 that were inhibited by PD98059, but not by a speci®c p38 kinase inhibitor, SB202190. Furthermore, no phosphorylated p38 was observed in both parental and 267B1/Ki-ras cells while the abundant expression level of unphosphorylated p38 was unaected by SB202190. Taken together, these data suggest that, in contrast to its role in Ha-Ras-induced NF-kB activation (Norris and Baldwin, 1999; Arsura et al., 2000) , p38 does not participate in the signaling pathway responsible for the activation of this transcription factor by Ki-Ras.
The proteasome inhibitor I inhibited the activation of NF-kB by Ki-Ras in a concentration-dependent manner (Figure 1b) , suggesting that the degradation of IkB is important in this process. EMSA analysis also revealed that proteasome inhibitor I inhibited the DNA binding activity of NF-kB in the nucleus, whereas PD98059 and SB202190 had no such eect ( Figure 1c ).
Role of IkBa, but not IkBb, in Ki-Ras-induced NF-kB activation
The possible in¯uence of serum factors on the constitutive activation of NF-kB in 267B1/Ki-ras cells was examined by determining the eect of serum deprivation on the abundance of NF-kB subunits as well as IkB proteins. Immunoblot analysis revealed that the amounts of p50 and p65 subunits of NF-kB in the nucleus (as well as that of p50 in the cytoplasm) were greater for the Ki-Ras-overexpressing cells. Consistent with this observation, the amount of IkBa in cytoplasmic extracts of 267B1/Ki-ras cells was reduced relative to that in such extracts of 267B1 cells (Figure 2a ). In contrast, the concentration of IkBb was greater in the cytoplasm of 267B1/Ki-ras cells than in that of 267B1 cells. Serum deprivation had no eects on the abundance of IkBa, IkBb, p50 or p65 in either cytoplasmic or nuclear extracts of either cell type.
IkBb has been shown to form a complex with NFkB in the nucleus, resulting in persistent activation of the transcription factor DeLuca et al., 1999) ; newly synthesized IkBa that translocates to the nucleus is not able to bind to and inactivate NF-kB present in this IkBb-NF-kB complex. Thus, the failure of antibodies to IkBb to induce a`supershift' in the NF-kB-DNA complex is consistent with the notion that the Ki-Ras-induced activation of NF-kB is mediated by the degradation of IkBa. To investigate which IkB protein is responsible for NF-kB activation by Ki-Ras, we examined the eects of IkBa and IkBb on the mobility of the complex of NF-kB with the oligonucleotide probe in EMSA analysis. Preincubation of 267B1/Ki-ras cell nuclear extract with the puri®ed IkBa protein prevented the binding of NF-kB to the DNA probe, whereas antibodies to either IkBa or IkBb had no eect on the interaction of NF-kB with the speci®c oligonucleotide (Figure 2b ). These observations were further examined by performing EMSA assays in the presence of 267B1/Ki-ras nuclear extracts with various concentrations of GST-IkBa (wt) or GSTIkBb (wt or mut) fusion proteins (Figure 2c ). The inhibition of NF-kB-DNA complex by GST-IkBa was consistent with the result obtained by using puri®ed IkBa as shown in Figure 2b . Furthermore, the observation that antibodies to either p65 or p50 (but not those to p52 or to c-Rel) reduced the mobility of the NF-kB-DNA complex (Figure 2b ) suggests that the active NF-kB dimer is composed of p65 and p50. This is consistent with immunoblot data showing that the abundance of these two proteins in the nuclear extract of 267B1/Ki-ras cells was greater than that in the corresponding extract of 267B1 (Figure 2a ). Preincubation of 267B1/Ki-ras cell nuclear extract with control proteins or antibodies, including glutathione S-transferase (GST), a GST-IKKa fusion protein, and antibodies to phospholipase C-g1, had no eect on the formation of the NF-kB-DNA complex. Ki-ras is indicated. As a control for quantitative analysis, the same membrane was deprobed and hybridized with antibodies to actin protein. (b) Luciferase reporter assay of NF-kB activation. Cells were cotransfected with 1 mg of pNF-kB-Luc and 1 mg of pCMV/bgal for 24 h, after which the activities of luciferase and bgalactosidase in cell lysates were determined. The luciferase activity was normalized on the basis of b-galactosidase activity and then expressed as fold increase relative to the normalized luciferase activity of 267B1 cells. Where indicated, PD98059 (PD, 4 mM), SB202190 (SB, 5 mM), or proteasome inhibitor I (Pr, 1 or 5 mg/ml) was added to the cells 1 h after transfection. Data are means+s.e. of triplicates from an experiment that was performed twice with similar results. (c) EMSA analysis of NF-kB activation. Cells were incubated for 24 h in the absence or presence of PD98059 at 50 mM, SB202190 at 50 mM, or proteasome inhibitor I at 5 mM, after which nuclear extracts were prepared and subjected to EMSA analysis with an oligonucleotide containing NF-kB binding sites. The position of the NF-kB-DNA complex (NF-kB) is indicated. (d) Using the cytoplasmic extracts prepared from cells treated with the same concentration of these inhibitors shown in panel (c), immunoblot analysis was performed for p42/p44 and p38. The membrane was probed with antibodies to either phosphorylated p42/p44 or p38. Antibodies to phosphorylated p38 showed no signal (data not shown)
The involvement of IkBa was further examined by determining phosphorylation and degradation of IkBa. Immunoblot analysis revealed that the extent of IkBa phosphorylation was markedly greater in 267B1/Ki-ras cells than in the parental 267B1 cells regardless of the absence or presence of serum (Figure 3a) . Serum had no eect on IkBa phosphorylation in either cell type. Whereas incubation of parental cells, 267B1, with TNF-a resulted in a marked increase in the extent of IkBa phosphorylation, this cytokine had no further eect on IkBa phosphorylation in 267B1/Ki-ras cells. Furthermore, the treatment of 267B1/Ki-ras cells with proteasome inhibitor I results in accumulation of IkB-a protein while TNF-a-induced IkB-a degradation as well as NF-kB-DNA binding activity were inhibited (Figure 3b) . No eect was observed on the Actin Figure 2 Involvement of IkBa on Ki-Ras-induced NF-kB activation. (a) Immunoblot analysis of IkBa, IkBb, and the NF-kB subunits p50 and p65. Both 267B1 and 267B1/Ki-ras cells were incubated for 24 h in complete medium or in serum-de®cient medium, after which cytoplasmic and nuclear extracts were subjected to immunoblot analysis with antibodies to IkBa, to IkBb, to p50, or to p65. The membrane was subsequently reprobed with antibodies to proliferating cell nuclear antigen (PCNA) or to actin as a control for nuclear and cytoplasmic extracts, respectively. (b) Characterization of the interaction of NF-kB in nuclear extracts of 267B1/Ki-ras cells with DNA. Nuclear extract of 267B1 or 267B1/Ki-ras cells was preincubated for 30 min in the absence or presence of puri®ed IkBa, GST, or GST-IKKa proteins (0.2 mg) or of antibodies (0.2 mg) to either IkBa, IkBb, p50, p52, p65, c-Rel, or phospholipase C-g1 (PLC-g1) before incubation in the EMSA reaction. The positions of the NF-kB-DNA complex and of supershifted complexes are indicated. (c) Eects of IkBa on NF-kB-DNA binding activity. Twenty-®ve to 100 ng of puri®ed fusion GST-IkBa or GST-IkBb protein were preincubated with nuclear extract of 267B1 or 267B1/Ki-ras cells for 30 min before incubation in the EMSA reaction. The position of the NF-kB-DNA complex is indicated expression levels. These results suggest that Ki-Ras alone is responsible for the constitutive activation of NF-kB in 267B1/Ki-ras cells, and that IkBa might play a role in this process.
We then determined the eect of chemical inhibitors, sulindac sul®de and farnesyltranferase inhibitor I speci®c for Ras activation, on Ki-Ras-induced NF-kB activation. When cells were treated with either sulindac sul®de or farnesyltranferase inhibitor I, phosphorylation of IkBa and NF-kB activation were markedly reduced in 267B1/Ki-ras cells (Figure 4a,b) , con®rming that Ki-Ras directs NF-kB activation in 267B1/Ki-ras cells.
Roles of NIK and IKKb in Ki-Ras-induced NF-kB activation
Given that IkBa phosphorylation is mediated by IKKa or IKKb (Ghosh et al., 1998; DiDonato et al., 1996) , we investigated which of these IKKs is responsible for this reaction in 267B1/Ki-ras cells. Transfection of these cells with an expression vector encoding a dominant negative mutant of IKKb (S177/181A) resulted in a decrease in the transactivation activity of NF-kB as well as phosphorylation of IkBa ( Figure  5a,b) , whereas transfection with a vector for wild-type IKKb increased luciferase activity in the reporter gene assay (Figure 5a ). In contrast, overexpression of either wild-type or a dominant negative mutant of IKKa (S176/180A) had minor eect on NF-kB activity and phosphorylation of IkBa in 267B1/Ki-ras cells.
NIK is a member of the MEKK family of kinases that acts immediately upstream of IKK and its overexpression induces NF-kB activation in many cell types (Karin and Delhase, 1998; Lin et al., 1998; Ling et al., 1998; Nakano et al., 1998; Nemoto et al., 1998) . Overexpression of a dominant negative mutant (K429/ 430A) of NIK reduced the extent of NF-kB activation as well as IkBa phosphorylation in 267B1/Ki-ras cells, whereas overexpression of the wild-type protein increased NF-kB activity in these cells (Figure 5a,b) . Overexpression of a dominant negative mutant of IkBa also inhibited NF-kB activation by Ki-Ras. This latter mutant, in which both Ser 32 and Ser 36 are replaced by Ala, is not susceptible to phosphorylation and is therefore not degraded in the cytosol and does not release NF-kB. Transfection of 267B1/Ki-ras cells with a vector encoding wild-type IkBa also resulted in inhibition of the transactivation activity of NF-kB, possibly as a result of translocation of newly synthesized IkBa to the nucleus and its binding to and inhibition of nuclear NF-kB.
To decipher the role of IKKb and NIK in NF-kB activation by Ki-Ras, the eect of chemical inhibitor, sulindac sul®de for Ras activation in 267B1/Ki-ras cells was determined by measuring relative luciferase activities. As shown in Figure 5c , Ki-Ras-induced NF-kB transactivation was drastically reduced and Both 267B1 and 267B1/Ki-ras cells were incubated for 24 h in complete medium or in serum-de®cient medium; at the end of the incubation without serum, the cells were exposed (or not) for 10 min to TNF-a (20 ng/ml). Cytoplasmic extracts were then prepared and subjected to immunoblot analysis with antibodies to phosphorylated IkBa (P-IkBa) or IkBa. The membrane was subsequently reprobed with antibodies to actin as a control for sample application. (b) Eect of proteasome inhibitor I on IkBa. Cytoplasmic extracts were prepared from the cells pretreated with proteasome inhibitor I at various concentrations followed by TNFa treatment as described in (a) and subjected to immunoblot analysis with antibodies to IkBa. The membrane was subsequently reprobed with antibodies to Akt as a control for sample application. Nuclear extracts were also subjected to the EMSA assay Figure 4 Inhibition of IkBa phosphorylation by Ras inhibitors, sulindac sul®de (S) and farnesyltransferase inhibitor I (F). Cells were treated with 5 mM of either inhibitor for 24 h and the cytoplasmic fractions were subjected to immunoblot analysis by using antibodies to phosphorylated IkBa or unphosphorylated IkBa. (b) The nuclear extracts prepared from the same condition in (a) were subjected to determine NF-kB-DNA binding activity by performing EMSA assay transfection of these cells with IKKb or NIK counteracted the eect of this inhibitor on NF-kB activation while IKKa confers no eect, consistent with a recent report (Yamamoto et al., 1999) .
Taken together, these results suggest that the activation of NF-kB by Ki-Ras is mediated by a signaling pathway that is comprised of NIK, IKKb and IkBa. However, the observation that the inhibition of NF-kB activity by mutant forms of NIK and IKKb was less marked than that observed with the IkBa mutant suggests the possible existence of an additional pathway that converges on IkBa.
Discussion
Substantial evidence has indicated that activated Ras induces the activation of NF-kB and thereby regulates genes associated with carcinogenesis (Arsura et al., 2000; Johnson et al., 2001; Wang and Richmond, 2001) . Proteins implicated in this signaling pathway include PI3K, MEKK and the MAPKs ERK and JNK (Finco et al., 1997; Romashkova and Makarov, 1999; Kimmelman et al., 2000; Tang et al., 2000; Caunt et al., 2001 ). H-Ras has thus been shown to activate NFkB through the MAPK p38 (Finco et al., 1997; Caunt et al., 2001) , which functions downstream of PI3K-Akt and the kinase known as SEK1 or MKK4 (Tang et al., 2000) . In the present study, however, the lack of an eect of speci®c inhibitors, PD98059 and SB202190, suggested that neither MEK nor p38 contributes to KiRas-induced activation of NF-kB. Rather, the activation of NF-kB by Ki-Ras was shown to be dependent on NIK and IKKb, given that dominant negative mutants of these two enzymes reduced the transactivation activity of NF-kB as well as IkBa phosphorylation in 267B1/Ki-ras cells. Furthermore, transfection of these cells with wild-type NIK or IKKb counteracted the eects of Ras inhibitor on NF-kB activation, but not by IKKa. We also showed that the extent of IkBa phosphorylation was increased in 267B1/Ki-ras cells compared with that in parental 267B1 cells, even though the amount of IkBa was reduced in 267B1/Kiras cells, suggesting that the degradation of IkBa by the proteasome is promoted by Ki-Ras. This conclusion was supported by our observation that the abundance of the NF-kB subunits p50 and p65 was increased in the nucleus of 267B1/Ki-ras cells relative to that in 267B1 cells. These results are also consistent with the previous observation that increased degradation of IkBa is responsible for the constitutive activation of NF-kB in mature murine B cells (Miyamoto et al., 1994) .
In contrast to the amount of IkBa, the abundance of IkBb was increased in 267B1/Ki-ras cells. IkBb is thought to be responsible of the persistent activation of NF-kB DeLuca et al., 1999) . Whereas newly synthesized IkBa migrates to the nucleus and prevents NF-kB from binding to DNA, the association of unphosphorylated IkBb with NF-kB in the nucleus prevents the interaction of the latter with IkBa. In contrast to results obtained with cells in which IkBb contributes to the persistent activation of NF-kB , however, our EMSA analysis did not detect a supershift in the NF-kB-DNA complex in response to incubation with anti-IkBb; moreover, exogenous IkBa protein, but not IkBb, inhibited the formation of this complex. These results thus indicate Eects of Ras inhibitor, sulindac sul®de (5 mM) on NF-kB transactivation activity. 267B1/Ki-ras cells were cotransfected with 1 mg of pNF-kB-Luc and 10 ng of plasmid DNA expressing either NIK, IKKa, or IKKb for 24 h; where indicated, sulindac sul®de (5 mM) was added to the cells 1 h after transfection. The relative luciferase activity of cell lysates was then determined as described in Figure 1b . Nontransfected 267B1 cells were similarly analysed as a control. Data are means+s.e. of triplicates from an experiment that was repeated twice with similar results that Ki-Ras-induced NF-kB activation is mediated through the phosphorylation and degradation of IkBa.
Taken together, our data suggest that Ki-Ras induces the nuclear translocation and activation of NF-kB through the NIK-IKKb-IkBa signaling pathway. Our data also showed that the activation of NFkB was not completely blocked by the dominant negative mutants of NIK and IKKb in 267B1/Ki-ras cells, suggesting the possible participation of another signaling pathway in this process. PI3K activates NFkB through the action of phosphatidylinositol-dependent kinase (PDK1 and 2) (Sizemore et al., 1999) . There is evidence suggesting that PI3K activates NFkB either through the IKK-IkBa pathway or by an IkB-independent mechanism (Ozes et al., 1999; Romashkova and Makarov, 1999; Sizemore et al., 1999) . Therefore, further investigation of the possible role of PI3K in NF-kB activation by Ki-Ras should provide insight into the mechanism by which Ki-Ras-induced signaling results in NF-kB regulation.
Materials and methods
Materials
TNF-a, T4 polynucleotide kinase, Lipofectin, and Lipofectamine Plus were obtained from GIBCO ± BRL. PD98059, SB202190, sulindac sul®de, farnesyltransferase inhibitor I, and proteasome inhibitor I were from Calbiochem. Puri®ed IkBa as well as antibodies to p50, to p52, to p65, to c-Rel, to IkBa, to IkBb, to IKKa, to IKKb, to actin, to PCNA and Ki-Ras were from Santa Cruz Biotechnology; antibodies to phospho-IkBa, phospho-MAPK, phospho-p38, and p38 and calf intestinal phosphatase (CIP) were from Cell Signaling. The luciferase assay kit was obtained from Promega, Sephadex G-25 columns and enhanced chemiluminescence reagents were from Amersham Pharmacia Biotech, the pNFkB-Luc plasmid was from Stratagene, and [g-32 P]ATP was from NEN. Recombinant GST, GST-IkBa, GST-IkBb, and the GST-IKKa fusion protein were produced and puri®ed in our laboratory. Plasmid DNA encoding wild-type (pCMV4-3HA/IkB-a) or mutant (pCMV4-3HA/ IkBS32/36A) forms of IkBa was provided by Dr WC Greene, (University of California, San Francisco, CA, USA). Mutation sites were con®rmed by automated sequence analysis. Plasmid encoding wild-type (pCMV2-IKK2) or mutant IKKb (pCMV2-IKK2-S177/181A) (Kwak et al., 2000) were provided by Dr Richard Gaynor, University of Texas Southwestern Medical Center (Dallas, Texas, USA). Mutant forms of IKKa (pFlag-IKK1-S176/180A) and NIK (pMyc-NIK-K429/430A) were generated by performing site-directed mutagenesis assays (Stratagene) using wild-type cDNA as templates (Regnier et al., 1997) provided by Dr Mike Rothe, Tularik Inc.
Cell culture and transfection
267B1 and 267B1/Ki-ras cells were maintained in RPMI 1640 medium supplemented with 2 mM L-glutamine, hydrocortisone (0.5 mg/ml) and 10% heat-inactivated fetal bovine serum, and were cultured in a humidi®ed CO 2 incubator at 378C. For luciferase reporter assays, cells (2610 5 /ml) were incubated in 6-well plates for 24 h; with the use of Lipofectamine Plus, they were then cotransfected with 1 mg of pNF-kB-Luc, 1 mg of pCMV/b-galactosidase plasmid, and 10 ng of a plasmid encoding either wild-type or mutant forms of IkBa, IKKa, IKKb or NIK. After 24 h, the cells were assayed for luciferase activity with a kit.
EMSA analysis
EMSA analysis was performed as described (Janssen and Sen, 1999) . In brief, cells (5610 6 in 10 ml) grown in 100 mm dishes were lysed on ice for 15 min in a hypotonic solution containing 10 mM HEPES-KOH (pH 7.8), 10 mM KCl, 2 mM MgCl 2 , 0.1 mM EDTA (sodium salt), 0.2 mM NaF, 0.2 mM Na 3 VO 4 , 0.4 mM phenylmethylsulfonyl¯uor-ide (PMSF), leupeptin (10 mg/ml), 1 mM dithiothreitol (DTT), and 0.6% NP-40. The lysate was centrifuged at 16 000 g for 1 min at 48C, and the resulting nuclear pellet was resuspended in ice-cold extraction buer (50 mM HEPES-KOH (pH 7.8), 50 mM KCl, 300 mM NaCl, 0.1 mM EDTA, 0.2 mM NaF, 0.2 mM Na 3 VO 4 , 0.4 mM PMSF, 1 mM DTT) and incubated for 30 min at 48C. The nuclear lysate was then centrifuged at 16 000 g for 15 min at 48C, and the resulting supernatant was stored at 7808C or immediately subjected to EMSA analysis. An oligonucleotide containing NF-kB binding site (3.5 pmol) (SantaCruz) was incubated for 30 min at 378C in 10 ml containing 10 mCi of [g-32 P]ATP, 5 U of T4 polynucleotide kinase, and 16kinase buer (supplied with the kinase). The labeling reaction was terminated by the addition of 100 mM EDTA, after which the reaction mixture was centrifuged through a Sephadex G-25 column to remove unincorporated 32 P. The 32 P-labeled oligonucleotide was then stored at 7808C until use. For the assay, nuclear protein extract (5 to 10 mg) was incubated for 30 min at room temperature in a ®nal volume of 10 ml containing 0.03 pmol of 32 P-end-labeled oligonucleotide, 40 mM HEPES-KOH (pH 7.8), 10% glycerol, 1 mM MgCl 2 , 0.1 mM DTT and 1 mg of poly(dI-dC). For supershift analysis, the nuclear extract was incubated with speci®c antibodies for 30 min at room temperature before addition of the labeled oligonucleotide. The binding reaction was terminated by the addition of electrophoresis sample buer, and the samples were fractionated on 6% nondenaturing polyacrylamide gels in 0.56Tris-boric acid-EDTA (TBE) buer. The gels were then subjected to autoradiography.
Immunoblot analysis
Cells were grown to subcon¯uency in 100 or 150 mm dishes. They were washed four times with ice-cold phosphatebuered saline and then scraped on ice into, and maintained for 15 min in, a solution containing 10 mM HEPES-KOH (pH 7.9), 10 mM KCl, 2 mM MgCl 2 , 0.1 mM EDTA, 0.2 mM NaF, 0.4 mM PMSF, leupeptin (10 mg/ml), aprotinin (10 mg/ ml), 0.1 mM Na 3 VO 4 , and 1 mM DTT. After the addition of NP-40 to a ®nal concentration of 0.5%, the lysate was vigorously mixed for 15 s and then centrifuged at 12 000 g for 1 min at 48C. The resulting supernatant was stored at 7808C as the cytoplasmic extract, and the nuclear pellet was resuspended in a solution containing 50 mM HEPES-KOH (pH 7.9), 50 mM KCl, 300 mM NaCl, 0.1 mM EDTA, 0.2 mM NaF, leupeptin (10 mg/ml), aprotinin (10 mg/ml), 0.4 mM PMSF, 0.1 mM Na 3 VO 4 , 1 mM DTT and 10% glycerol. The resulting suspension was incubated for 30 min on ice and then centrifuged at 12 000 g for 30 min at 48C. Equal amounts of cytoplasmic or nuclear extract were subsequently fractionated by SDS-polyacrylamide gel electrophoresis. The separated proteins were transferred to a polyvinylidene di¯uoride membrane and subjected to immunoblot analysis with speci®c antibodies; immune complexes were detected with enhanced chemiluminescence reagents.
